• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

DiMe Launches Partnerships to Combat Opioid Relapse Using Wearables

by Fred Pennic 04/29/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– The Digital Medicine Society (DiMe), a global non-profit focused on digital medicine, today announced a partnership uniting healthcare providers, universities, technology companies, and research centers. 

– The initiative will explore the use of data from consumer wearable devices, like smartwatches and rings, to predict and ultimately prevent relapse among individuals with opioid use disorder (OUD), potentially saving thousands of lives.

– Partners in this crucial effort include Alcohol and Drug Services (ADS), Duke University, Google Fitbit, Morse Clinics, North Carolina Central University, ŌURA, ProofPilot, Triangle CERSI, and the University of North Carolina at Chapel Hill (UNC).

Opioid Epidemic Impact 

The opioid epidemic continues to exact a heavy toll in the United States, with an estimated 5.7 million people living with OUD and approximately 81,000 dying annually from opioid overdoses. A critical factor contributing to these tragic statistics is the high rate of relapse experienced by those in recovery, which significantly increases the risk of overdose and death.

Currently, routine clinical care lacks effective mechanisms to detect the subtle signs of impending relapse in a person’s daily life. This initiative seeks to bridge that gap. Recognizing the advancements in consumer technology, the collaboration proposes that real-time sensor data, collected passively through wearables and actively via smartphones, could hold the key.

Project Focus & Approach

The project will focus on identifying and measuring physiological signals and behavioral traits associated with relapse risk. Data points gathered from wearables like Fitbit and ŌURA rings will include heart rate variability, sleep patterns (insomnia), physical activity levels, and indicators of physiological stress. Simultaneously, smartphones will be used to capture self-reported data on mental health characteristics such as social isolation, anxiety, and depression.

Using advanced AI and machine learning algorithms, the collected data will be analyzed to identify patterns predictive of relapse. The ultimate goal is to develop a validated digital tool that can alert individuals and potentially their care providers to heightened relapse risk, enabling timely interventions before a return to opioid use occurs.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |